ASX Health Stocks: PainChek wins European patent; Phase 3 Trial set to begin for Opthea
PainChek granted patent in Europe PainChek (ASX:PCK) has been granted a patent in 20 European nations by the European Patent Office (EPO). The patent was given for the PainChek app, an AI platform designed to analyse facial expressions, vocalisations, …